Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02903238 · ClinicalTrials.gov registry record · NA
Brain Morphometry in OA Patients Treated With Duloxetine
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02903238 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 21 participants.
The verdict
NCT02903238, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This is a two week,single-blind study evaluating pain response and changes in brain imaging upon treatment with placebo in people with knee OA.
Interventions
- DRUG Duloxetine
- DRUG Placebo Oral Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2011-07 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02903238
The ClinicalTrials.gov registry entry for NCT02903238 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Duloxetine is the first listed.
NCT02903238 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02903238 about?
NCT02903238 is a clinical study titled "Brain Morphometry in OA Patients Treated With Duloxetine". This is a two week,single-blind study evaluating pain response and changes in brain imaging upon treatment with placebo in people with knee OA.
What is the current status of trial NCT02903238?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2011-07. Estimated completion is 2011-12.
What interventions are being tested in trial NCT02903238?
The interventions under investigation include: Duloxetine (DRUG), Placebo Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT02903238?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.